HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: Analysis of the responding population and mechanism of cytotoxic lymphocyte activation

Immunology

Volumn 88, Issue 3, 1996, Pages 428-440

  Geary, S M ^a   Ashman, L K ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD16 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL LINE; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKEMIA CELL; MIXED LYMPHOCYTE REACTION; MYELOID LEUKEMIA; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0030011356     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-668.x     Document Type: Article

References (51)

1. ASHMAN L.K. (1987) The immunogenicity of tumour cells, Immunol Cell Biol 65, 271.
2. O'KEEFE D. & ASHMAN L. (1982) Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines. Immunology 47, 633.
3. ASHMAN, L.K., KRIEK G.W., COOPER S.J. & O'KEEFE D.E, (1987) Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells. Cancer Immunol Immunother 25, 250.
4. LEE S.K. & OLIVER R.T.D. (1978) Autologous leukemia-specific T-cell mediated lymphocytotoxicity in patients with acute myelogenoiis leukemia. J Exp Med 147, 912.
5. ASHMAN L.K., O'KEEFE D.E., JUTTNER C.A., TOOGOOD I.R.G. & RICE M.S. (1986) Autologous responses to human leukaemic cells in mixed leukocyte culture. Cancer Immunol Immunother 22, 95.
6. HOROWITZ M.M., GALE R.P., SONDEL P.M. et al. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555.
7. JIANG Y.Z., KANFER E.J., MACDONALD D., CULLIS J.O., GOLDMAN J.M. & BARRETT A.J. (1991) Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. Bone Marrow Transplantation 8, 253.
8. VAN DER BRUGGEN P., TRAVERSARI C., CHOMEZ C. et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643.
9. VAN DEN EYNDE B., LETHE B., VAN PEL A., DE PLAEN E. & BOON T. (1991) The gene coding for a major tumour rejection antigen of tumour P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173, 1373.
10. BOON T. (1992) Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res 58, 177.
11. BRICHARD V., VAN PEL A., WOLFEL T. et al. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178, 489.
12. COLLINS S.J., GALLO R.C. & GALLAGHER R.E. (1977) Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270, 347.
13. DALTON W.T., AHEARN M.A., MCCREDIE K.B., FREIREICH E.J., STASS S.A. & TRUJILLO J.M. (1988) HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71, 242.
14. DE THE H., CHOMIENNE C., LANOTTE M., DEGOS L. & DEJEAN A. (1990) The t(15:17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor-α gene to a novel transcribed locus. Nature 347, 558.
15. LARSON R.A., KONDO K., VARDIMAN J.W., BUTLER A.G., GOLOMB H.M. & ROWLEY J.D. (1984) Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Ant J Med 76, 827.
16. TODD R.F., GRIFFIN J.D., RITZ J., NAYLOR L.M., ABRAMS T. & SCHLOSSMAN S.F. (1981) Expression of normal monocyte-macrophage differentiation antigens on HL-60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. Leak Res 5, 491.
17. HEMMI H. & BREITMAN T.R. (1987) Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukaemia cell line HL-60. Blood 69, 501.
18. TRINCHIERI G., KOBOYASHI M., ROSEN M., LOUDON R., MURPHY M. & PERUSSIA B. (1986) Tumour necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 164, 1206.
19. BREITMAN T.R., SELONICK S.E. & COLLINS S.J. (1980) Induction of differentiation of the human promyelocytic cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77, 2936.
20. SANTOLI D., FRANCIS M.K., MATERA L. & FERRERO D. (1983) Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukaemic cell lines and of normal peripheral blood granulocytes. J Immunol 131, 736.
21. CASTAIGNE S., CHOMIENNE C., DANIEL M.T. et al. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. 1. Clinical results. Blood 76, 1704.
22. FENAUX P., CATAIGNE S., DOMBRET H. et al. (1992) All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukaemia: a pilot study on 26 cases. Blood 80, 2176.
23. GALLAGHER R., COLLINS S., TRUJILLO J. et al. (1979) Characterization of the continuous differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54, 713.
24. YAM L.T., LI C.Y. & CROSBY W.H. (1971) Cytochemical identification of monocytes and granulocytes. Am J Clin Path 55, 283.
25. KNAPP W., Dörken B., GILKS W.R. et al. (eds) (1989) Leucocyte Typing IV. White Cell Differentiation Antigens, Oxford University Press, Oxford.
26. COLE S.R., ASHMAN L.K. & EY P.L. (1987) Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates. Mol Immunol 24, 699.
27. BOYD A.W., WAWRYK S.O., BURNS G.F. & FECONDO J.V. (1988) Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sd USA 85, 3095.
28. SANCHEZ-MADRID F., KRENSKY A.M., WARE C.F. et al. (1982) Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2 and LFA-3. Proc Natl Acad Sci USA 79, 7489.
29. STERN A.S., PODLASKI F.J., HULMES J.D. et al. (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87, 6808.
30. BROUDY V.C., LIN N., ZSEBO K.M. et al. (1992) Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 73, 338.
31. ASHMAN L.K., BUHRING H.-J., AYLETT G.W., BROUDY V.C. & MULLER C. (1994) Epitope mapping and functional studies with three monoclonal antibodies to the C-KIT receptor tyrosine kinase. YB5.B8, 17F1I and SR-1. J Cell Physiol 158, 545.
32. YISRAELI J.K. & MELTON D.A. (1989) Synthesis of long capped transcripts in vitro by SP6 and T7 RNA polymerases. Methods Enzymol 180, 42.
33. SAMBROOK J., FRITSCH E.F. & MANIATIS T. (1989) Molecular Cloning: A Laboratory Manual, edn 2. Cold Springer Harbor Press, Cold Spring Harbor.
34. COLE S.R., AYLETT G.W., CASEY G., HARVEY N.L., CAMBARERI A.C. & ASHMAN L.K. (1996) Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia. Leukaemia 10, 288.
35. TANG G.W. & RUSSEL R.M. (1988) 13-cis-retinoic acid is an endogenous compound in human blood. FASEB J 2, A1094.
36. + T cells to mount primary proliferative and cytotoxic responses to Ia tumour cells. Nature 322, 541.
37. - natural killer cells. J Exp Med 171, 1527.
38. NAGLER A., LANIER L.L., CWIRLA S. & PHILLIPS J.H. (1989) Comparative studies of human FcR III-positive and negative natural killer cells. J Immunol 143, 3183.
39. + natural killer cells: a comparative study. J Immunol 147, 2208.
40. LEE M., HIROWAKA M. & MIURA A.B. (1993) Mechanisms of allogeneic stimulation induced tumour necrosis factor-α (TNF-α) production. Leuk Res 17, 89.
41. LEE J.C., TRUNEH A., SMITH M.F. Jr & TSANG K.Y. (1987) Induction of IL-2 receptor (Tac) by tumour necrosis factor in YT cells. J Immunol 139, 1935.
42. LOWENTHAL J.W., BALLARD D.W., BOGERD H., BOHNLEIN E. & GREENE W.C. (1989) Tumour necrosis factor-alpha activation of the IL-2 receptor involves the induction of kappa B-specific DNA binding proteins. J Immunol 142, 3121.
43. FREEMAN G.J., GRIBBEN J.G., BOUSSIOTIS V.A. et al. (1993) Cloning of B7-2: a CTLA-4 counter receptor that costimulates human T cell proliferation. Science 262, 909.
44. BUTINI L., DE FOUGEROLLES A.R., VACCARREZZA M. et al. (1994) Intercellular adhesion molecules (ICAM)-1, ICAM-2 and ICAM-3 function as counter receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation. Eur J Immunol 24, 2191.
45. ALTMANN D.M., HOGG N., TROWSDALE J. & WILKINSON D, (1989) Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen presenting cell function in mouse L cells. Nature 338, 512.
46. LINSLEY P.S., GREENE J., TAN P. et al (1992) Coexpression and functional cooperativity of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 176, 1595.
47. - T cells. AIDS 8, 431.
48. CICCONE E., PENDE D., VIALE O. et al. (1992) Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 176, 931.
49. CASTAIGNE S., CHOMIENNE: C., DANIEL M.T. et al. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. 1. Clinical results. Blood 76, 1704.
50. HUANG, M., YE H.-C., CHEN S.-R. et al. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood 72, 567.
51. CHOMIENNE, C., BALLERINI P., BALITRAND N. et al. (1990) All-trans retinoic acid in acute promyelocytic leukaemias. II. In vitro studies: structure function relationship. Blood 76, 1710.